3494 articles
Large study reveals striking differences in how pregnant women with autoimmune diseases continue biologic treatments, with IBD patients far more likely to continue than those with psoriasis.
First real-world evidence shows maternal RSV vaccination during pregnancy dramatically reduces severe respiratory illness in newborns.
Study reveals optimal timing for maternal RSV vaccination to maximize antibody transfer to babies.
Scientists explore how mRNA vaccine technology could revolutionize tuberculosis prevention and treatment strategies.
Phase 3 trial demonstrates significant motor function improvements with single intrathecal dose of onasemnogene abeparvovec.
Pfizer's bivalent RSV vaccine demonstrated high efficacy and strong immune responses in adults 60+ across two respiratory virus seasons.
Study finds biological therapies achieve 50% sustained remission vs 12% with conventional drugs in rare inflammatory disease.
Phase 3 trial demonstrates 87% protection rate with single-dose vaccine in older adults most vulnerable to severe disease.
Real-world study of 20 children shows adding risdiplam after gene therapy improved motor, breathing, and swallowing function in spinal muscular atrophy.
Clinical trial finds standard HPV vaccination significantly reduces actinic keratosis burden in adults with multiple lesions.
Comprehensive analysis of 14 trials reveals RSV vaccines reduce respiratory illness by up to 77% in older adults and 74% in infants through maternal vaccination.
Machine learning approach combining plasma biomarkers with traditional risk factors improves cardiovascular disease prediction and risk stratification.
